Inhibition of Melanogenesis by the Antidiabetic Metformin
- 1 October 2014
- journal article
- Published by Elsevier in Journal of Investigative Dermatology
- Vol. 134 (10) , 2589-2597
Abstract
No abstract availableKeywords
Funding Information
- Institut National de la Santé et de la Recherche Médicale
- Université Nice Sophia Antipolis
- Association pour la Recherche sur le Cancer (SFI 20121205378)
This publication has 23 references indexed in Scilit:
- A chemical biology approach identifies AMPK as a modulator of melanoma oncogene MITFOncogene, 2013
- Biguanides suppress hepatic glucagon signalling by decreasing production of cyclic AMPNature, 2013
- AMP-Activated Protein Kinase: A Target for Drugs both Ancient and ModernChemistry & Biology, 2012
- AMP-activated kinase (AMPK)-generated signals in malignant melanoma cell growth and survivalBiochemical and Biophysical Research Communications, 2010
- p38 Regulates Pigmentation via Proteasomal Degradation of TyrosinaseJournal of Biological Chemistry, 2010
- Hypopigmenting agents: an updated review on biological, chemical and clinical aspectsPigment Cell Research, 2006
- Melanin Pigmentary Disorders: Treatment UpdateDermatologic Clinics, 2005
- Genetic disorders of pigmentationClinics in Dermatology, 2005
- Activation of cAMP-Dependent Protein Kinase Is Required for Optimal α-Melanocyte-Stimulating Hormone-Induced PigmentationExperimental Cell Research, 1998
- DHICA Oxidase Activity of TRP1 and Interactions With Other Melanogenic EnzymesPigment Cell Research, 1994